Research / ZM / Fundamental state Inspectable configuration
State dimensions Filing 0001585521-26-000121 General Corporate
Capex intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.75% · OPTIONAL · VALID
Operating cash generation 40th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
38.74% · OPTIONAL · VALID
Revenue growth 65th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
4.93% · CORE · VALID
Gross margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
77.16% · CORE · VALID
Operating margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
24.61% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
18.99% · OPTIONAL · VALID
SBC intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
14.08% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Oct 31, 2021 0/7 normalized Level 3 Jan 31, 2022 6/7 normalized Level 3 Apr 30, 2022 6/7 normalized Level 3 Jul 31, 2022 6/7 normalized Level 3 Oct 31, 2022 6/7 normalized Level 3 Jan 31, 2023 7/7 normalized Level 3 Apr 30, 2023 7/7 normalized Level 3 Jul 31, 2023 7/7 normalized Level 3 Oct 31, 2023 7/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.70%
Current 1.75%
Delta 0.05% Cash Generation Decreased
Previous 42.10%
Current 38.74%
Delta -3.36% Growth Decreased
Previous 5.47%
Current 4.93%
Delta -0.54% Margin Decreased
Previous 77.86%
Current 77.16%
Delta -0.70% Profitability Decreased
Previous 25.06%
Current 24.61%
Delta -0.45% R And D Intensity Increased
Previous 18.40%
Current 18.99%
Delta 0.59% Sbc Intensity Decreased
Previous 14.44%
Current 14.08%
Delta -0.37% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Apr 30, 2026
Similarity 89%
Compared 7 dimensions
Coverage 100% Growth 0.0 · Margin 10.0 · Profitability 5.0 · Sbc Intensity 5.0 · Capex Intensity 5.0 · Cash Generation 25.0 · R And D Intensity 10.0 Oct 31, 2024
Similarity 77%
Compared 7 dimensions
Coverage 100% Growth 25.0 · Margin 16.6 · Profitability 27.9 · Sbc Intensity 42.9 · Capex Intensity 3.7 · Cash Generation 12.6 · R And D Intensity 0.0 Jul 31, 2025
Similarity 74%
Compared 7 dimensions
Coverage 100% Growth 15.0 · Margin 15.0 · Profitability 15.0 · Sbc Intensity 20.0 · Capex Intensity 30.0 · Cash Generation 20.0 · R And D Intensity 50.0 Apr 30, 2024
Similarity 72%
Compared 7 dimensions
Coverage 100% Growth 41.9 · Margin 14.4 · Profitability 11.2 · Sbc Intensity 43.8 · Capex Intensity 24.1 · Cash Generation 30.6 · R And D Intensity 5.9 Jan 31, 2022
Similarity 69%
Compared 6 dimensions
Coverage 86% Margin 10.0 · Profitability 7.5 · Sbc Intensity 60.0 · Capex Intensity 32.5 · Cash Generation 15.0 · R And D Intensity 25.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.